Pharmacist Moms Group^™

In this episode, the panel reflects on how this program can help pharmacists strengthen their approach to tardive dyskinesia (TD) recognition and management.

Explore effective strategies for managing side effects in patients, emphasizing communication, monitoring, and education for optimal health outcomes.

In this episode, the panel discusses how pharmacists and the broader care team can support adherence and strengthen communication when patients start deutetrabenazine or valbenazine.

Explore the real-world challenges and strategies for patient adherence in treatment, emphasizing education and shared decision-making for better outcomes.

KTX-1001, a novel oral inhibitor of NSD2, demonstrates early clinical activity and manageable safety in heavily pretreated multiple myeloma.

Pharmacists adapt to new CDC guidelines, emphasizing pneumococcal vaccination for adults 50+, enhancing patient screening and vaccination efficiency.

Experts discuss groundbreaking data on pancreatic cancer treatment, revealing a 64% survival rate and its potential to transform patient care and outcomes.

Pharmacists play a critical role in improving access to and affordability of GLP-1 therapies.

New findings on myelofibrosis treatments reveal the impact of anemia on survival and the benefits of momelotinib for transfusion independence.